Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q1 2015 13F Holders as of 31 Mar 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 64,472,950
- Share change
- +6,409,044
- Total reported value
- $6,731,323,619
- Put/Call ratio
- 131%
- Price per share
- $104.42
- Number of holders
- 236
- Value change
- +$672,355,194
- Number of buys
- 149
- Number of sells
- 80
Report period
Q1 2015
Institutions
236
Top holders
10
ALNY full security history
Newer quarter: Q2 2015
Previous quarter: Q4 2014
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.7%
|
11,539,663
|
$1,119,347,000 | — | 31 Dec 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.7%
|
8,947,136
|
$867,872,000 | — | 31 Dec 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
3,720,774
|
$360,916,000 | — | 31 Dec 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
2,138,486
|
$207,435,000 | — | 31 Dec 2014 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.5%
|
1,950,269
|
$189,176,000 | — | 31 Dec 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.2%
|
1,603,283
|
$155,518,000 | — | 31 Dec 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
1,601,754
|
$155,370,000 | — | 31 Dec 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.1%
|
1,455,332
|
$141,167,000 | — | 31 Dec 2014 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
1,375,405
|
$133,413,000 | — | 31 Dec 2014 | |
| Alpha Wave Global, LP |
13F
|
Company |
1%
|
1,367,713
|
$132,668,000 | — | 31 Dec 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.93%
|
1,242,026
|
$120,477,000 | — | 31 Dec 2014 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.82%
|
1,093,430
|
$106,062,000 | — | 31 Dec 2014 | |
| STATE STREET CORP |
13F
|
Company |
0.8%
|
1,070,610
|
$103,852,000 | — | 31 Dec 2014 | |
| Capital World Investors |
13F
|
Company |
0.73%
|
965,312
|
$93,635,000 | — | 31 Dec 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.71%
|
942,971
|
$91,468,000 | — | 31 Dec 2014 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.64%
|
857,683
|
$83,195,000 | — | 31 Dec 2014 | |
| Slate Path Capital LP |
13F
|
Company |
0.64%
|
855,000
|
$82,935,000 | — | 31 Dec 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.62%
|
820,115
|
$79,551,000 | — | 31 Dec 2014 | |
| BB BIOTECH AG |
13F
|
Company |
0.56%
|
751,288
|
$72,875,000 | — | 31 Dec 2014 | |
| 12 West Capital Management LP |
13F
|
Company |
0.49%
|
651,000
|
$63,147,000 | — | 31 Dec 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.49%
|
648,428
|
$62,898,000 | — | 31 Dec 2014 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
564,439
|
$54,751,000 | — | 31 Dec 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
556,276
|
$53,959,000 | — | 31 Dec 2014 | |
| NORGES BANK |
13F
|
Company |
0.42%
|
552,661
|
$53,608,000 | — | 31 Dec 2014 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
528,608
|
$51,275,000 | — | 31 Dec 2014 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.36%
|
483,213
|
$46,872,000 | — | 31 Dec 2014 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
0.36%
|
477,700
|
$46,337,000 | — | 31 Dec 2014 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
0.32%
|
430,000
|
$41,710,000 | — | 31 Dec 2014 | |
| Global Thematic Partners, LLC |
13F
|
Company |
0.3%
|
405,799
|
$39,362,000 | — | 31 Dec 2014 | |
| Artal Group S.A. |
13F
|
Company |
0.3%
|
400,000
|
$38,800,000 | — | 31 Dec 2014 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.28%
|
374,048
|
$36,283,000 | — | 31 Dec 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
347,962
|
$33,752,000 | — | 31 Dec 2014 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.26%
|
340,395
|
$33,018,000 | — | 31 Dec 2014 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.22%
|
291,382
|
$28,264,000 | — | 31 Dec 2014 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.21%
|
284,291
|
$27,576,000 | — | 31 Dec 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
276,265
|
$26,797,000 | — | 31 Dec 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
266,318
|
$25,834,000 | — | 31 Dec 2014 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.19%
|
250,732
|
$24,321,000 | — | 31 Dec 2014 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.19%
|
249,472
|
$24,199,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
209,946
|
$20,363,000 | — | 31 Dec 2014 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.14%
|
191,259
|
$18,552,000 | — | 31 Dec 2014 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.13%
|
170,407
|
$16,529,000 | — | 31 Dec 2014 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.13%
|
168,728
|
$16,367,000 | — | 31 Dec 2014 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.12%
|
166,368
|
$16,138,000 | — | 31 Dec 2014 | |
| FIC CAPITAL INC |
13F
|
Company |
0.12%
|
159,182
|
$15,441,000 | — | 31 Dec 2014 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.11%
|
145,695
|
$14,133,000 | — | 31 Dec 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
132,122
|
$12,816,000 | — | 31 Dec 2014 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.1%
|
130,243
|
$12,634,000 | — | 31 Dec 2014 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.1%
|
129,400
|
$12,552,000 | — | 31 Dec 2014 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
124,362
|
$12,063,000 | — | 31 Dec 2014 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q1 2015
As of 31 Mar 2015,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,472,950 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital World Investors, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, MORGAN STANLEY, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
236
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
214
Q1 2015 holders
236
Holder diff
22
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.